The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer

Journal of Clinical Oncology

Volumn 12, Issue 12, 1994, Pages 2640-2647

  Johnston, Patrick G ^a   Fisher, Edwin R ^b   Rockette, Howard E ^b   Fisher, Bernard ^b   Wolmark, Norman ^b   Drake, James C ^b   Chabner, Bruce A ^b   Allegra, Carmen J ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; LOMUSTINE; MONOCLONAL ANTIBODY; THYMIDYLATE SYNTHASE; VINCRISTINE;

ADJUVANT CHEMOTHERAPY; ARTICLE; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER STAGING; CANCER SURVIVAL; DISEASE ASSOCIATION; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RECTUM CANCER; SURVIVAL RATE;

EID: 0028151449     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1994.12.12.2640     Document Type: Article

References (38)

1. Moertel CG: Current concepts in cancer: Chemotherapy of gastrointestinal cancer. N Engl J Med 299:1049-1052, 1978
2. Danenberg PV: Thymidylate synthase: A target enzyme in cancer chemotherapy. Biochim Biophys Acta 473:73-92, 1977
3. Santi DV, McHenry CS, Sommer M: Mechanisms of interaction of thymidylate synthase with 5-fluorodeoxyuridylate. Biochemistry 13:471-480, 1974
4. Santi DV, Danenberg PV: Mechanisms of interaction of thymidylate synthase with 5-fluorodeoxyuridylate folates in pyrimidine nucleotide biosynthesis, in Blakely RL, Benkovic SJ (eds): Folates and Pterins. New York, NY, Wiley, 1984, pp 385-398
5. Berger SH, Chung-Her J, Johnson LF, et al: Thymidylate synthase overproduction and gene amplification in fluorodeoxyuridine-resistant human cells. Mol Pharmacol 28:461-467, 1987
6. Clark JL, Berger SL, Mittelman A, et al: Thymidylate synthase gene amplification in a colon tumor resistant to fluoropyrimidine chemotherapy. Cancer Treat Rep 71:261-265, 1987
7. Spears CP, Antranik AH, Moran RG, et al: In vivo kinetics of thymidylate synthase inhibition in 5-fluorouracil-sensitive and -resistant murine colon adenocarcinomas. Cancer Res 42:450-456, 1982
8. Washtein WL: Increased levels of thymidylate synthase in cells exposed to 5-fluorouracil. Mol Pharmacol 25:171-177, 1984
9. Johnston PG, Drake JC, Trepel J, et al: Immunological quantitation of thymidylate synthase using the monoclonal antibody TS 106 in 5-fluorouracil-sensitive and -resistant human cancer cell lines. Cancer Res 52:4306-4312, 1992
10. Swain SM, Lippman ME, Egan EF, et al: Fluorouracil and high-dose leucovorin in previously treated patients with metastatic breast disease. J Clin Oncol 7:890-896, 1989
11. Chu E, Koeller D, Johnston PG, et al: The regulation of thymidylate synthase in human colon cancer cells treated with 5-fluorouracil and interferon-gamma. Mol Pharmacol 43:527-533, 1993
12. Moran RG, Spears CP, Heidelberger C: Biochemical determinants of tumor sensitivity to 5-fluorouracil: Ultrasensitive methods for the determination of 5-fluoro-2-deoxyuridylate and thymidylate synthase. Proc Natl Acad Sci USA 76:1456-1460, 1979
13. Roberts D: An isotope assay for thymidylate synthetase. Biochemistry 5:3546-3548, 1966
14. Johnston PG, Liang CM, Henry S, et al: The production and characterization of monoclonal antibodies that localize human thymidylate synthase in the cytoplasm of human cells and tissues. Cancer Res 51:6668-6676, 1991
15. Krook J, Moertel C, Gunderson LL, et al: Effective surgical adjuvant chemotherapy for high-risk rectal carcinoma. N Engl J Med 324:709-715, 1991
16. Fisher B, Wolmark N, Rockette H, et al: Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J Natl Cancer Inst 80:21-29, 1988
17. National Institutes of Health Consensus Conference: Adjuvant therapy for patients with colon and rectal cancer. JAMA 264:1444-1450, 1990
18. Hsu SM, Raine L, Fanger H: A comparative study of the peroxidase-antiperoxidase method and an avidin biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am J Clin Pathol 75:734-738, 1981
19. Kaplan EL, Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 53:457-458, 1958
20. Cutler SJ, Ederer F: Maximum utilization of the life-table method in analyzing survival. J Chronic Dis 8:699-712, 1958
21. Peto R, Peto J: Asymptotically efficient rank invariant test procedures. J R Stat Soc A 135:185-206, 1972
22. Cox DR: Regression models and life tables. J R Stat Soc 34:187-220, 1972
23. Fisher ER, Sass R, Palekar A, et al: Dukes' classification revisited. Cancer 64:2354-2360, 1989
24. Dukes CE, Bussey HJR: The spread of rectal cancer and its effect on prognosis. Br J Cancer 12:309-320, 1958
25. Astler VB, Coller FA: The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg 139:846-852, 1954
26. Wanebo HJ, Rao B, Pinsky C: Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. N Engl J Med 299:446-451, 1978
27. Scott N, Wieand H, Moertel C, et al: Colorectal cancer Dukes' stage tumor site, preoperative CEA plasma level and patient prognosis related to tumor DNA ploidy pattern. Arch Surg 122:1375-1379, 1987
28. Sun X-F, Cartensen JM, Zhang H, et al: Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma. Lancet 340:1369-1373, 1992
29. Sikora K, Chan S, Evan G, et al: C-myc- oncogene expression in colorectal cancer. Cancer 59:1289-1295, 1987
30. Gallick GE, Kurzock R, Kloetzer WS, et al: Expression of p21 ras in fresh primary and metastatic human colorectal tumors. Proc Natl Acad Sci USA 82:1795-1799, 1985
31. Bauer KD, Lincoln ST, Vera-Roman JM, et al: Prognostic implications of proliferative activity and DNA aneuploidy in colonic adenocarcinomas. Lab Invest 57:329-335, 1987
32. Witzig TE, Loprinzi CL, Gonchoroff NJ, et al: DNA ploidy and cell kinetic measurements as predictors of recurrence and survival in stages B2 and C colorectal cancer. Cancer 68:879-888, 1991
33. Chang KJ, Enker WE, Melamed M: Influence of tumor cell DNA ploidy on the natural history of rectal cancer. Am J Surg 153:184-188, 1987
34. Fisher ER, Siderits RH, Sass R, et al: Value of assessment of ploidy in rectal cancers. Arch Pathol Lab Med 113:525-528, 1989
35. Navalgund LG, Rossano C, Muench AJ, et al: Cell cycle regulation of thymidylate synthase gene expression in cultured mouse fibroblasts. J Biol Chem 255:7386-7390. 1980
36. Pestalozzi BC, McGinn CJ, Trepel J, et al: Immunological quantitation of thymidylate synthase and cell cycle in 5-fluorouracil-sensitive and -resistant human cancer cell lines. Proc Am Assoc Cancer Res 34:415, 1993 (abstr)
37. Chu E, Voeller DM, Jones KL, et al: Identification of a thymidylate synthase ribonucleoprotein complex in human colon cancer cells. Mol Cell Biol 14:207-213, 1994
38. Lenz H-J, Horikoshi T, Leichman CG, et al: Thymidylate synthase gene expression predicts response of gastric tumors to 5-FU leucovorin cisplatin. Proc Am Soc Clin Oncol 12:199, 1993 (abstr)